サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676278

疼痛管理治療薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Pain Management Therapeutics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 128 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
疼痛管理治療薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

疼痛管理治療薬の世界市場規模は、2024年の861億3,000万米ドルから、2033年までには1,249億5,000万米ドルに成長すると予測され、2026年から2033年の予測期間中に4.22％の堅調な年間平均成長率（CAGR）を示します。

疼痛管理治療薬市場は、慢性疼痛の世界の負担が増大し続けていることから、大幅な成長を遂げる見通しです。関節炎、神経障害、線維筋痛症などの症状を患う人が増加する中、効果的な疼痛緩和ソリューションに対する需要が最も高まっています。同市場では、非オピオイド代替療法や多剤併用療法が重視されるようになり、よりホリスティックで患者中心のアプローチへとシフトしています。この動向の背景には、オピオイド使用に伴うリスクに対する意識の高まりがあり、ヘルスケアプロバイダーは、中毒の可能性を伴わずに疼痛に対処する革新的な治療法の探求を促しています。

バイオテクノロジーと薬理学の開発は、新規疼痛管理治療薬の開発に道を開いています。モノクローナル抗体や遺伝子治療を含む生物学的製剤は、特定の疼痛経路を標的とする有望な選択肢として台頭しており、より効果的で個別化された治療レジメンの可能性を提供しています。さらに、ウェアラブルデバイスやモバイルアプリケーションなどのデジタルヘルス技術の統合は、リアルタイムのモニタリングやデータ収集を可能にし、疼痛管理に革命をもたらしています。これらの技術革新は、患者が疼痛管理に積極的に関与できるようにするだけでなく、ヘルスケア専門家に治療計画をより効果的に調整するための貴重な知見を提供します。

疼痛管理治療薬市場の将来は、革新的治療薬への患者のアクセスを優先する規制の変更や償還政策によっても左右されます。非オピオイド系治療薬の有効性を裏付ける臨床エビデンスが増え続ける中、規制機関はこれらの代替薬の承認プロセスを迅速化し、競合情勢を促進する可能性が高いです。さらに、包括的な疼痛管理戦略の価値を認める償還の枠組みが確立されれば、ヘルスケアプロバイダーはこうした革新的なソリューションを採用するようになると思われます。市場が成熟するにつれ、疼痛管理をより広範なヘルスケア戦略に統合する方向に焦点が移り、疼痛の身体的側面と心理的側面の両方に対処することの重要性が強調されるようになると思われます。このような総合的なアプローチは、患者の予後を向上させるだけでなく、ヘルスケアシステム全体の効率化にも貢献します。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をクライアントに提供するために綿密に作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています：

市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳します。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価をします。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 疼痛管理治療薬産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル開発動向

第5章 疼痛管理治療薬の世界市場分析：疼痛タイプ別

  • 概要：疼痛タイプ別
  • 実績データと予測データ分析：疼痛タイプ別
  • 慢性
  • 急性

第6章 疼痛管理治療薬の世界市場分析：薬剤クラス別

  • 概要：薬剤クラス別
  • 実績データと予測データ分析：薬剤クラス別
  • 非ステロイド性抗炎症薬
  • 麻酔薬
  • 抗けいれん薬
  • 抗偏頭痛薬
  • 抗うつ薬
  • オピオイド
  • 非麻薬
  • 鎮痛薬

第7章 疼痛管理治療薬の世界市場分析：適応症別

  • 概要：適応症別
  • 実績データと予測データ分析：適応症別
  • 関節痛
  • 神経障害性疼痛
  • がん性疼痛
  • 慢性疼痛
  • 術後疼痛
  • 片頭痛
  • 線維筋痛症
  • 骨折
  • 筋肉
  • 捻挫・挫傷
  • 急性虫垂炎
  • その他

第8章 疼痛管理治療薬の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 疼痛管理治療薬企業の競合情勢

  • 疼痛管理治療薬市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Johnson & Johnson
  • Novartis International AG
  • Merck & Co. Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Abbott Laboratories
  • Teva Pharmaceuticals
  • Eli Lilly And Company
  • Endo Health Solutions Inc.
  • Allergan Inc.
  • Covidien Plc
  • Durect Corporation
  • Hospira Inc.
  • Mundipharma International Ltd.
  • Forest Laboratories Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Pain Type (USD MN)
  • Chronic Market Sales By Geography (USD MN)
  • Acute Market Sales By Geography (USD MN)
  • Analysis By Drug Class (USD MN)
  • NSAIDS Market Sales By Geography (USD MN)
  • Anesthetics Market Sales By Geography (USD MN)
  • Anticonvulsant Market Sales By Geography (USD MN)
  • Anti-migraine Drugs, Market Sales By Geography (USD MN)
  • Antidepressant Drugs Market Sales By Geography (USD MN)
  • Opioids Market Sales By Geography (USD MN)
  • Non-narcotics Market Sales By Geography (USD MN)
  • Analgesics Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Arthritic Pain Market Sales By Geography (USD MN)
  • Neuropathic Pain Market Sales By Geography (USD MN)
  • Cancer Pain Market Sales By Geography (USD MN)
  • Chronic Pain Market Sales By Geography (USD MN)
  • Post-operative Pain Market Sales By Geography (USD MN)
  • Migraine Market Sales By Geography (USD MN)
  • Fibromyalgia Market Sales By Geography (USD MN)
  • Bone Fracture Market Sales By Geography (USD MN)
  • Muscle Market Sales By Geography (USD MN)
  • Sprain/Strain Market Sales By Geography (USD MN)
  • Acute Appendicitis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Pain Management Therapeutics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Pain Management Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Pain Management Therapeutics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Pain Type
  • Market Attractiveness Analysis By Drug Class
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Pain Type (USD MN)
  • Chronic Market Sales By Geography (USD MN)
  • Acute Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug Class (USD MN)
  • NSAIDS Market Sales By Geography (USD MN)
  • Anesthetics Market Sales By Geography (USD MN)
  • Anticonvulsant Market Sales By Geography (USD MN)
  • Anti-migraine Drugs, Market Sales By Geography (USD MN)
  • Antidepressant Drugs Market Sales By Geography (USD MN)
  • Opioids Market Sales By Geography (USD MN)
  • Non-narcotics Market Sales By Geography (USD MN)
  • Analgesics Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Arthritic Pain Market Sales By Geography (USD MN)
  • Neuropathic Pain Market Sales By Geography (USD MN)
  • Cancer Pain Market Sales By Geography (USD MN)
  • Chronic Pain Market Sales By Geography (USD MN)
  • Post-operative Pain Market Sales By Geography (USD MN)
  • Migraine Market Sales By Geography (USD MN)
  • Fibromyalgia Market Sales By Geography (USD MN)
  • Bone Fracture Market Sales By Geography (USD MN)
  • Muscle Market Sales By Geography (USD MN)
  • Sprain/Strain Market Sales By Geography (USD MN)
  • Acute Appendicitis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11213511

Global Pain Management Therapeutics Market size is anticipated to grow from USD 86.13 Billion in 2024 to USD 124.95 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.22% during the forecast period of 2026 to 2033.

The pain management therapeutics market is set to experience substantial growth as the global burden of chronic pain continues to escalate. With an increasing number of individuals suffering from conditions such as arthritis, neuropathy, and fibromyalgia, the demand for effective pain relief solutions is paramount. The market is witnessing a shift towards more holistic and patient-centered approaches, with a growing emphasis on non-opioid alternatives and multimodal therapies. This trend is driven by the rising awareness of the risks associated with opioid use, prompting healthcare providers to explore innovative treatments that address pain without the potential for addiction.

Advancements in biotechnology and pharmacology are paving the way for the development of novel pain management therapeutics. Biologics, including monoclonal antibodies and gene therapies, are emerging as promising options for targeting specific pain pathways, offering the potential for more effective and personalized treatment regimens. Additionally, the integration of digital health technologies, such as wearable devices and mobile applications, is revolutionizing pain management by enabling real-time monitoring and data collection. These innovations not only empower patients to take an active role in their pain management but also provide healthcare professionals with valuable insights to tailor treatment plans more effectively.

The future of the pain management therapeutics market will also be influenced by regulatory changes and reimbursement policies that prioritize patient access to innovative therapies. As clinical evidence supporting the efficacy of non-opioid treatments continues to grow, regulatory bodies are likely to expedite the approval processes for these alternatives, fostering a more competitive landscape. Furthermore, the establishment of reimbursement frameworks that recognize the value of comprehensive pain management strategies will encourage healthcare providers to adopt these innovative solutions. As the market matures, the focus will shift towards integrating pain management into broader healthcare strategies, emphasizing the importance of addressing both physical and psychological aspects of pain. This holistic approach will not only enhance patient outcomes but also contribute to the overall efficiency of healthcare systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Pain Type

  • Chronic
  • Acute

By Drug Class

  • NSAIDS
  • Anesthetics
  • Anticonvulsant
  • Anti-migraine Drugs,
  • Antidepressant Drugs
  • Opioids
  • Non-narcotics
  • Analgesics

By Indication

  • Arthritic Pain
  • Neuropathic Pain
  • Cancer Pain
  • Chronic Pain
  • Post-operative Pain
  • Migraine
  • Fibromyalgia
  • Bone Fracture
  • Muscle
  • Sprain/Strain
  • Acute Appendicitis
  • Others
  • COMPANIES PROFILED
  • Johnson & Johnson
  • Novartis International AG
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Abbott Laboratories
  • Teva Pharmaceuticals
  • Eli Lilly and Company
  • Endo Health Solutions Inc.
  • Allergan Inc.
  • Covidien plc
  • Durect Corporation
  • Hospira Inc.
  • Mundipharma International Ltd.
  • Forest Laboratories Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PAIN MANAGEMENT THERAPEUTICS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Pain Type
    • 3.7.2 Market Attractiveness Analysis By Drug Class
    • 3.7.3 Market Attractiveness Analysis By Indication
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY PAIN TYPE

  • 5.1. Overview By Pain Type
  • 5.2. Historical and Forecast Data Analysis By Pain Type
  • 5.3. Chronic Historic and Forecast Sales By Regions
  • 5.4. Acute Historic and Forecast Sales By Regions

6. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

  • 6.1. Overview By Drug Class
  • 6.2. Historical and Forecast Data Analysis By Drug Class
  • 6.3. NSAIDS Historic and Forecast Sales By Regions
  • 6.4. Anesthetics Historic and Forecast Sales By Regions
  • 6.5. Anticonvulsant Historic and Forecast Sales By Regions
  • 6.6. Anti-migraine Drugs, Historic and Forecast Sales By Regions
  • 6.7. Antidepressant Drugs Historic and Forecast Sales By Regions
  • 6.8. Opioids Historic and Forecast Sales By Regions
  • 6.9. Non-narcotics Historic and Forecast Sales By Regions
  • 6.10. Analgesics Historic and Forecast Sales By Regions

7. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY INDICATION

  • 7.1. Overview By Indication
  • 7.2. Historical and Forecast Data Analysis By Indication
  • 7.3. Arthritic Pain Historic and Forecast Sales By Regions
  • 7.4. Neuropathic Pain Historic and Forecast Sales By Regions
  • 7.5. Cancer Pain Historic and Forecast Sales By Regions
  • 7.6. Chronic Pain Historic and Forecast Sales By Regions
  • 7.7. Post-operative Pain Historic and Forecast Sales By Regions
  • 7.8. Migraine Historic and Forecast Sales By Regions
  • 7.9. Fibromyalgia Historic and Forecast Sales By Regions
  • 7.10. Bone Fracture Historic and Forecast Sales By Regions
  • 7.11. Muscle Historic and Forecast Sales By Regions
  • 7.12. Sprain/Strain Historic and Forecast Sales By Regions
  • 7.13. Acute Appendicitis Historic and Forecast Sales By Regions
  • 7.14. Others Historic and Forecast Sales By Regions

8. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PAIN MANAGEMENT THERAPEUTICS COMPANIES

  • 9.1. Pain Management Therapeutics Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF PAIN MANAGEMENT THERAPEUTICS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Johnson & Johnson
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Novartis International AG
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Merck & Co. Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. GlaxoSmithKline Plc
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Pfizer Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Abbott Laboratories
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Teva Pharmaceuticals
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Eli Lilly And Company
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Endo Health Solutions Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Allergan Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Covidien Plc
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Durect Corporation
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Hospira Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Mundipharma International Ltd.
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Forest Laboratories Inc
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies